WEST COLUMBIA, S.C., June 8, 2023 ~ Nephron Pharmaceuticals Corporation has announced the appointment of Christopher Fortier, PharmD, FASHP, CPEL as President of its 503B Outsourcing Facility. In this role, Fortier will be responsible for overseeing all operations at the facility which produces sterile medications for hospitals and medical facilities across America.

Lou Kennedy, CEO and Owner of Nephron commented on the appointment: "Chris has not only the education and skill, but also the knowledge of what major hospitals and pharmacies around the country need every day. That combination will be an invaluable asset to the Nephron team."

Prior to joining Nephron, Fortier was Chief Pharmacy Officer at Massachusetts General Hospital in Boston. He chaired the Mass General Brigham Chief Pharmacy Officer's Council and was responsible for leading large-scale pharmacy initiatives at the health system level. He has served in healthcare leadership roles for numerous state and national professional organizations, has been published in multiple healthcare journals, and has been featured in a variety of media outlets including NBC Nightly News, the Associated Press, the Wall Street Journal, National Public Radio, Bloomberg, and the Washington Post.

More on Boston Chron

• City of Boston Announces Early Voting Locations
• City of Boston Announces Early Voting Locations
• One Of The Largest Native American Burial Sites In The United States Moves A Step Closer To National Recognition
• UNITED AIRLINES TEAMSTERS RALLY NATIONWIDE FOR STRONG CONTRACT
• Cummings Graduate Institute for Behavioral Health Studies Announces New Book: Integrated Behavioral Health: Applying the Biodyne Mindset in Healthcare

Fortier received his Doctor of Pharmacy from University of Connecticut and completed a PGY-1/PGY-2 Health-System Pharmacy Administration Residency at Medical University of South Carolina Medical Center in Charleston. He is a Fellow of American Society of Health System Pharmacists (ASHP) and certified as a Pharmacy Executive Leader by ASHP. He serves as chair of University of Connecticut School of Pharmacy Board of Directors and vice chair United Way of Greater New Bedford Board of Directors.

Nephron develops and produces safe generic inhalation solutions and suspension products as well as operates an industry-leading 503B Outsourcing Facility division which produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals across America to alleviate drug shortage needs. For more information visit www.nephronpharm.com

---

Show All News | Report Violation